📊 Score Breakdown
Offering Ability
20
Cash Runway
65
Float Risk
2
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
⛈️
Warning
High probability of dilution event
37%
🔄 Reverse Split
65%
• 50-day avg $0.23 below $1 exchange minimum
• 10 months cash with weak price
💰 Capital Raise
15%
• Under 12 months cash (10mo)
💹 Market Data
Market Cap$21.28M
Shares Outstanding105.86M
Float100.89M
Cash$1.88M
DebtN/A
Short InterestN/A
🏛 Institutional Holdings
Institutional data not yet available.
📉 Short Interest
Short Interest1.9K
Days to Cover1.0
% of FloatN/A
FINRA data as of Mar 31, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Sep 30, 2022
xbrl
XBRL CONVERTIBLE
Sep 30, 2021
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for TARSF
📊 TARSF FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 TARSF Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.